000 01925nam  2200397zi 4500
0019.912983
003CaOODSP
00520221107182704
006m     o  d f      
007cr cn|||||||||
008220630t20222022onca    ob   f000 0 eng d
020 |a9780660443690
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-316/2022E-PDF
24500|aProcess for incorporating economic evidence into federal vaccine recommendations.
250 |aVersion 1.0
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2022.
264 4|c©2022
300 |a1 online resource (15 pages) : |billustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |a"February 2022."
500 |a"Protecting and empowering Canadians to improve their health."
500 |aAt head of title: National Advisory Committee on Immunization (NACI).
500 |aIssued also in French under title: Processus d'intégration des données économiques dans les recommandations fédérales relatives aux vaccins.
504 |aIncludes bibliographical references (page 15).
520 |a"The NACI Economic Process is a document that outlines when and how NACI incorporates economic evidence for vaccine recommendation"--Preamble, page 4.
650 0|aVaccination|xEconomic aspects|zCanada.
650 0|aVaccines|xEconomic aspects|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
7101 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body.
77508|tProcessus d'intégration des données économiques dans les recommandations fédérales relatives aux vaccins.|w(CaOODSP)9.912982
85640|qPDF|s1.58 MB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-316-2022-eng.pdf